Compounding Pharmacy/Adulterated Drug Products
Similar Posts
Somerset Therapeutics Private Limited – 711340 – 09/04/2025
CGMP/Finished Pharmaceuticals/AdulteratedCohance Lifesciences Limited – 718812 – 01/30/2026
CGMP/Finished Pharmaceuticals/AdulteratedClinical Outcome Assessments (COA) Qualification Program Resources
Resources and information for requestors interested in CDER’s Clinical Outcome Assessments (COA) Qualification Program.This update contains the Letter of Intent Template for the COA Qualification Program, as described under section 507 of the Federal Food, Drug, and Cosmetic Act.
FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).Cosmetic Manufacturers Pty Ltd. – 719225 – 02/06/2026
CGMP/Finished Pharmaceuticals/AdulteratedPrimavera Nueva Inc. Issues Voluntary Recall of Select 4-Count Tamales Because of Possible Health Risk
Sonoma, CA — Primavera Nueva Inc. is voluntarily recalling certain lots of its 4-count tamales because the products have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and ot